Christophe Tournerie

Founder and CEO of ClinActis Pte Ltd.

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.